Various studies have focused on understanding how the continuous positive air pressure (CPAP) treatment improves the emotional state of obstructive sleep apnea patients, as well as factors that determine improvement. Yet the results are contradictory. The objective of the present study was to evaluate the changes in depression levels, anxiety state and anxiety trait levels of patients with obstructive sleep apnea after 1 month and again after 3 months of CPAP treatment. The sample consisted of 51 obstructive sleep apnea patients. The Beck Depression Inventory (BDI) standardized spanish version was used to assess depressive symptoms. The State-Trait Anxiety Inventory (STAI) was used to assess two elements of the response to anxiety: anxiety-state and anxiety-trait. The results indicate that there exist statistically significant differences in depression levels after 1 month and after 3 months of treatment (P < 0.05). In specific, a drop in depression symptomatology was observed in both experimental conditions. With respect to anxiety statetrait levels, the obtained results show statistically significant differences in anxiety-trait levels after 1 month and after 3 months of treatment (P < 0.05) and in anxiety state after 3 months of treatment (P < 0.01). Both variables experienced a decrease after CPAP treatment.
INTRODUCTION
There are many studies on the relationship between sleep and the emotional state. This relationship has been laid out as bi-directional. In one direction, some studies indicate that sleep deprivation produces mood changes in healthy subjects, while the other direction has observed that in 90% of major depression patients there exist sleep alterations, and in some cases physiological sleep disorders can persist even after a clinical remission for depression. In trying to explain this relationship, many hypotheses have been considered. One of the possibilities arisen considers that this high rate of sleep disorders in depressive subjects is due to the inappropriate sleep habits that these subjects acquire. Furthermore, it can also be considered that the depression and the sleep alterations are overlapped by determined pathological and physiological mechanisms. 1 Various studies have considered depression to be a very frequent symptom of sleep apnea. However, the majority of the studies fail to agree upon the actual prevalence rate of this symptom. Another identified problem in dealing with this topic is that very few studies have investigated whether there is a relationship between depression severity and the degree of sleep fragmentation or the level of oxygen saturation during sleep. 2 Mosko et al. completed a study with sleep disorder patients, which included narcolepsy, sleep apnea and periodic limb movements. 3 The study results revealed a high frequency of major depression symptoms being reported by patients. Within the group of evaluated subjects, it was found that approximately one-quarter described themselves as depressed and between 58% and 71% of patients reported symptoms during the last 5 years that were consistent with major depression episodes. Mosko et al. have various explanations for this elevated depression symptomatology found in the patients. These explanations include the pathophysiology of the sleep disorder itself, the use of chronic medication, the presence of other concomitant medical problems, and the presence of other affective disorders. Watson et al. correlated the Beck Depression Inventory and sleep apnea syndrome and found significant correlation between the depressive symptomatology and the total number of obstructive apneas and the frequency of apneas-hypopneas per hour of sleep. 4 Despite the results of the previous studies, as mentioned earlier, there exist a number of controversies with respect to the relationship that exists between depression and the severity of obstructive sleep apnea syndrome (OSAS). Millman et al. measured the depression symptomatology of a group of OSAS patients and concluded that the severity of the disorder was associated with an increase in depression symptomatology. 2 Although they did not find a significant correlation between the depression symptoms and the severity of the sleep apnea, they did observe that patients who scored within the range of a clinical depression had a higher number of respiratory events than patients who did not score within the range. However, Pillar and Lavie did not observe any relation between anxiety and depression and the severity of OSAS in men. 5 They did, however, find that women with OSAS showed significantly higher levels of depression and anxiety than men and that those women who presented with severe OSAS had significantly higher depression levels than women with mild OSAS.
As occurred in the case of depression, it is important to consider that the relationship between sleep changes and high anxiety levels has also been studied bi-directionally. Some studies point out that patients with determined anxiety disorders (e.g. general anxiety, panic attacks or posttraumatic stress disorder etc.), suffer sleep alterations. 6 The studies also show that sleep disorders, like obstructive apnea, which seriously affect the quality of life in patients, provoke higher anxiety levels as well as changes in mood. In this sense, cases have been observed where anxiety levels of severe OSAS patients have correlated positively with the apnea-hypopnea index. 7 Currently, the elected treatment for sleep apnea is continuous positive air pressure (CPAP). Some studies reveal that the CPAP therapy improves the quality of life for sleep apnea patients. Millman et al. applied the CPAP treatment to a group of OSAS patients and found that the treatment improved depression symptomatology in some of the patients without the need to apply any type of combined antidepressive therapy. 2 These depression patients presented with such symptoms as fatigue, interrupted sleep and delayed psychomotor. The patients had a state of general dissatisfaction with respect to their lifestyle, with complaints of irritability, despair and low self-esteem, although they did not report being sad, the need to cry, nor having suicide thoughts. In contrast, Mosko et al. measured the effectiveness, in this case, of surgery treatment for the depression symptomatology of sleep apnea patients. 3 The results showed an improvement in the depression symptoms for patients of this type, in particular for symptoms such as anger, fatigue, and depression. However, as happens with other characteristics of this disorder, contradictory results have also been found. This contradiction is found in the study carried out by Borak et al. with severe OSAS patients. 7 They did not observe any improvement in the emotional state of the patients after 3 months and again after 1 year of CPAP treatment.
The objective of the present study was to measure the effectiveness of the CPAP treatment on levels of depression, state anxiety, and trait anxiety of OSAS patients after 1 month and 3 months of CPAP treatment.
METHOD Subjects
The sample used was selected from a hospital and comprised 51 patients with OSAS (47 men and four women). The age range varied between 30 and 65 years of age (mean ± SD, 48.04 ± 8.64). In order to establish a OSAS diagnosis, a determined number of apneas and hypoapneas per hour of sleep are needed. There currently exist many controversies about establishing the cut-off point between normal sleep and OSAS. In general, the presence of five or 10 apneas/hypoapneas per hour of sleep is considered as pathological. This controversy is also accompanied by a high index of therapy abandonment by patients with a small degree of OSAS. For this reason, and given that all patients diagnosed with OSAS were to receive CPAP therapy, the apnea-hypopnea index (AHI) used in the present study to establish the OSAS diagnosis was of 10 AHI per hour of sleep.
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Instruments
Cardio-respiratory polygraphy of every hour of sleep for each one patient
During the last few years, OSAS diagnosis has seen a great change. The polysomnograph is the most recommended method of evaluation. However, due to the high frequency of the disorder and the high cost included in this diagnostic procedure, new alternatives demonstrated to be equally as effective in diagnosing the disorder have been suggested. 9, 11 Among the new alternatives is the cardio-respiratory polygraph. 8 This diagnostic method has been the second most used in Spain. 10 It is also important to point out that the benefit of these new simplified techniques is not only reflected in the diagnosis, but also in making it possible for the disorder to be treated in a greater number of patients.
The cardio-respiratory polygraphy, a simplified procedure that consists of nighttime monitoring of: (i) electrocardiogram, (ii) respiratory movements, which evaluate the respiratory force, manifested by the expansion and relaxation of the thorax and abdomen, (iii) oronasal flow, and (iv) oxygen saturation.
Beck Depression Inventory
The Beck Depression Inventory standardized Spanish version 12 evaluated the depression symptomatology.
State-Trait Anxiety Inventory
The State-Trait Anxiety Inventory (STAI) 13 evaluated two elements of the response to anxiety: anxiety state and anxiety trait.
Questionnaire dealing with sleep apnea symptoms
A questionnaire dealing with sleep apnea symptoms 14 evaluated the level of symptomatology presented by the OSAS patient in a variety of areas that affect daily functioning as well as the nocturnal symptoms. The questionnaire consists of 25 items, each ranging in score from 0 (indicating absence of a symptom) to 3 (indicating the maximum presence of a symptom).
Nasal CPAP Sullivan V System and CPAP PV 100 System
Both systems were used as disorder treatment. The treatments consist of an air generator, a face mask, an air tube to connect the air generator to the face mask, an adjustable band to the hold face mask on the head, and a small pad for the nose.
Procedure
All of the patients were submitted to a medical exam and a medical interview in which a detailed clinical history of each patient was compiled. The clinical history consisted of information concerning the patient's symptomatology, family and personal backgrounds, consumption of alcohol and tobacco, information as to when the symptoms such as snoring and sleepiness began, and information dealing with other associated disorders such as movement of the extremities, somniloquia, etc.
An interview with each subject was then held in order to eliminate any possible psychopathological disorders (mainly depression disorders and/or anxiety disorders).
Subsequently, a cardio-respiratory polygraphy, registering 8 h of sleep, was applied to each patient with the objective of establishing a diagnosis for a disorder. When the polygraphy was completed, the following parameters, which indicate the presence or absence of a disorder and its severity, were analyzed: (i) total number of nocturnal obstructive apneas, their minimum and maximum duration and the apnea index which is obtained by dividing the total number of apneas by the number of hours of sleep; (ii) total number of hypopneas, their minimum and maximum duration, and the hypopneas index which is obtained by dividing the total number of hypopneas by the number of hours of sleep; (iii) value of saturation during the night and the mean fall; (iv) mean and minimum levels of SaO 2 %; and (v) apneas-hypopneas index.
At the time of establishing a sleep apnea diagnostic, the criterion established was an apnea-hypopnea index above 10. The obstructive apneas were defined as the cessation of airflow during sleep accompanied by respiratory movements lasting longer than 10 s. The hypopnea was defined as an episode in which the partial obstruction of the upper airway causes a significant decrease in the airflow. Once the recording of the hours of sleep was completed, the measuring of mood variables took place the following morning. The tests were completed between 08:30 and 11:30 h in the morning. All of the psychological tests were completed in the same place and under the same conditions for each one of the subjects, yet administered individually. Within the experimental procedure, the following variables were controlled: age, environmental variables (light, noise, temperature), food ingestion, time at which each evaluation was completed, consumption of alcohol or tobacco, etc.
Once the evaluation was completed, a second cardio-respiratory polygraphy was applied to the patients diagnosed with sleep apnea, where the treatment preparation was carried out. All of the patients were treated with continuous positive nasal pressure with pressures that oscillated between 5 and 12 cm H 2 O. Upon the conclusion of this phase, the patient was given an appointment, at approximately 1 month and 3 months, to begin the CPAP therapy. At this therapy, the evaluation of the mood variables would be repeated. Only 44 patients were evaluated at 1 month of therapy, while 36 patients were evaluated at 3 months. This reduction in the sample was not entirely due to therapy abandonment. In some cases the patients did not attend the appointment on the given date and were evaluated at a later date. However, these subjects were not included in the analysis, given that the post-therapy period was to be similar for all patients.
All statistical analysis were made with the statistics package SPSS version 8.0 Spanish version.
RESULTS
In Table 1 , the means and standard deviations of the total sample of 51 patients are shown. They include the total number of obstructive apneas, the total number of hypopneas, the SaO 2 , the AHI, the per cent of the total number of nocturnal apneas/hypopneas, and the per cent of the total time that each subject remained with an SaO 2 level below 90%, before and after the CPAP treatment.
Results after 1 month of treatment
From the initial sample of 51 obstructive sleep apnea patients, is been able accomplish the follow-up of the treatment to 44 patients. The approximate use of the CPAP during nocturnal rest hours was approximately 5.51 h.
A variance analysis was completed with repeated measures from the patients' mood variable scores. In relation to the depression variable, the results of the variance analysis indicate that there exists a significant principal effect on the treatment factor, F 1,42 = 4.40, P < 0.04. This shows that statistically significant differences can be observed in the depression levels after 1 month of CPAP treatment (P < 0.05). Specifically, as seen in Table 2 , the CPAP treatment produces a decrease in the depression levels after 1 month of initiating the therapy.
With respect to the state anxiety variable, the variance analysis with repeated measures indicates that there exists no significant principal effect of the treatment factor. In other words, no statistically significant differences can be observed between the baseline and the first month of CPAP treatment on state anxiety levels.
Finally, in relation to the trait anxiety variable, a significant principal effect on the treatment factor was observed, F 1,42 = 7.04, P < 0.011. Therefore, differences exist in trait anxiety between the baseline and the first month of treatment (P < 0.05). As shown in Table 2 , after 1 month of CPAP treatment, a decrease in the trait anxiety levels is produced with respect to the pretreatment situation. Table 1 . Mean scores and standard deviations of the total sample of 51 patients for the total number of obstructive apneas, hypopneas, oxygen saturation level (SaO 2 ), apnea-hypopnea index, percentage of total time of apneas/hypopneas and the total saturation time inferior to 90% during nocturnal rest hours, before and after the one night of CPAP treatment 
Results after 3 months of treatment
From the initial sample of 51 obstructive sleep apnea patients, is been able accomplish the follow-up of the treatment to 36 patients. The approximate use of the CPAP during nocturnal rest hours was approximately 5.81 h. In itself, a second variance analysis was completed with repeated measures from the patients' mood variable scores at 3 months of treatment. In relation to the depression variable, a significant principal effect on the treatment factor is found, F 1.34 = 6.61, P < 0.015; which shows that there exist statistically significant differences in the depression levels after 3 months of CPAP treatment (P < 0.05). As shown in Table 3 , the CPAP produces a decrease in the depression levels at 3 months of treatment.
With respect to the state anxiety variable, the variance analysis with repeated measures indicates that there exists a significant principal effect on the treatment factor, F 1.34 = 7.73, P < 0.009. Therefore, differences exist in state anxiety between the baseline and the 3 months of treatment (P < 0.01). As shown in Table 3 , the treatment with CPAP at 3 months produces a decrease in the state anxiety levels.
Finally, in relation to the trait anxiety variable, a significant principal effect on the treatment factor was observed, F 1.34 = 6.71, P < 0.014. After 3 months of CPAP treatment, there exist statistically significant differences in the trait anxiety levels (P < 0.05). As shown in Table 3 , CPAP produces a decrease in the trait anxiety levels at 3 months of treatment.
DISCUSSION
The results of our study indicate that the CPAP therapy produces an improvement in the mood of OSAS patients. At 1 month and at 3 months of treatment, a decrease is produced in the depression levels, with respect to the pretreatment situation. The revised literature is contradictory and there are no conclusive results with respect to the rate of depression in sleep apnea and what effect the treatment has on the affective state of the patient. Lee believed that through all of the literature the importance of depression symptoms on sleep apnea had been emphasized too much. 15 He wrote that he had observed cases of OSAS patients who presented some type of depression symptom, above all mood changes, that were totally coherent with the quality of life associated with OSAS. He did not find any case of OSAS where the depression symptomatology was sufficient enough to establish a major depression diagnosis as the DSM-III-R establishes. However, Ramos-Platon and Espinar Sierra, using the MMPI, found that the scores of OSAS patients were elevated in some of the questionnaire scales. 16 The patients presented concretely, paranoid ideas and their scores on the depression, schizophrenia, and hypochondriac scales were elevated. Once the treatment was established, they observed an improvement in the patients' psychosocial adaptation, as well as a decrease in scores of the previous scales that were much more pronounced after 1 year of treatment, in particular, for the depression and the degree of total adjustment.
One of the possible explanations for these results can be found in the evaluation instrument that was used. 5 In our case, the Beck Depression Inventory 12 is an instrument that collects 21 items referring to specific manifestations of depressive behavior. Within these items, there are items that make reference to, among others, mood, irritability, social isolation, labor capacity, indecision, sleep disorders, tiredness and libido, which can be modified after CPAP treatment. Many patients, before receiving the treatment, are forced to leave their job and to stop driving due to levels of tiredness that they experience during the day, associated mainly to sleep fragmentation. Some patients report problems in their sexual relations and many admit to having an irritable character, causing them to lose friendships and their capacity to make decisions. Once the treatment is established and the daytime tiredness is decreased, many patients regain their jobs, improving their nighttime sleep, their mood during the day, and their social-professional relationships. This improvement could explain the decrease in the depression levels. In relation to the state trait anxiety levels, the results of the present study indicate that the CPAP treatment produces a decrease in the trait anxiety levels at 1 and 3 months of treatment. A decrease is also observed in the state anxiety levels at 3 months of treatment. As happened with depression symptoms, these changes can be attributed mainly to the changes in the quality of life that the treatment induces. However, the results are contradictory to those observed by Borak et al. 7 They did not find any changes in the anxiety levels of OSAS patients after the CPAP treatment.
One possible explanation is that anxiety has been variable throughout the length of the literature that has been associated with other sleep disorders, as is the case with insomnia and even more so with sleep apnea. 5 This could determine the causes of its origin as well as the causes that determine the changes after CPAP treatment. We measured the levels of trait anxiety using the State-Trait Anxiety Inventory, 13 where the anxiety variable is defined as the tendency, by part of the subject, to perceive situations as threatening and to consequently elevate their levels of state anxiety. In other words, we are talking about people who display feelings of melancholy, hopelessness, and incapability that can be mainly determined by the quality of life associated to the disorder. Furthermore, it has been widely shown that the quality of life of these patients improves after the treatment, which at the same time can increase and improve the patient's emotional stability.
